Background: Drug prescription studies provide a pharmacoeconomic basis for making evidence-based health-care decisions. In ophthalmology practice, rational prescribing shows a vital role in decreasing the ocular disease burden. Purpose: The purpose of the study was to inspect the drug consumption pattern in ophthalmology department of King Abdulaziz hospital in KSA. Materials and Methods: A prospective, cross-sectional study was conducted for a period of 3 months. The prescriptions for all consecutive patients attending the ophthalmology outpatient department for the first time (first time encounter) were incorporated and reviewed using a pre-designed form to record information from the ophthalmology outpatient department prescription cards of each patient. Data analysis was carried out using the descriptive statistical methods: frequencies, mean, percentage, and standard deviation. Results: A total of 500 prescriptions were considered with the average number of drugs per prescription being 2.2 (0.8). The most common disorders diagnosed were eyelid diseases (31.6%) followed by foreign body in the eye (23,2%), conjunctivitis (20,8%), glaucoma, conrneal ulcer, squint, and others. Drugs were prescribed in different dosage forms with eye drops being the most common (62.9%) followed by ointment (20.5%), capsule (8.6%), and tablets (8.0%) of all dosage forms. The frequency of drug management and period of treatment was recorded in 94% and 76% of all prescriptions respectively. Drugs were predominantly prescribed in brand name rather than generic name. Conclusion: The current study showed certain lacunae in the prescribing practices of the ophthalmologists of the institute as showed by low generic prescribing, insufficient information about frequency of management and period of treatment in many prescriptions. This can be addressed over appropriate sensitization of clinicians in the art of rational prescribing.
Background: Latest studies have shown effective clinical outcomes after arthroscopic Bankart repair (ABR) but have shown some risk factors for re-dislocation after surgery. We assessed whether patients are at a risk for re-dislocation during the first year after ABR, examined the recurrence rate after ABR, and sought to recognize new risk factors. Materials and Methods: We performed ABR utilizing bioabsorbable suture anchors in 51 consecutive shoulders (50 patients) with traumatic anterior shoulder instability. Average patient age was 26.5 (range, 15-40) years. We assessed re-dislocation after ABR using patient telephone interviews (follow-up rate, 100%) and correlated re-dislocation with several risk factors. Results: Re-dislocation after ABR occurred in five shoulders (9.8%), of which 4 sustained re-injuries within the first year with the arm elevated at 90° and externally rotated at 90°. Of the remaining 46 shoulders without re-dislocation, 4 had re-injury under the same conditions within the first year. Consequently, re-injury within the first year was a risk for re-dislocation after ABR (P < 0.001, chi-squared test). Using multivariate analysis, large Hill-Sachs lesions (odds ratio, 6.75; 95% CI, 1.35-64.5) and <4 suture anchors (odds ratio, 9.45; 95% CI, 1.88-72.5) were significant risk factors for re-dislocation after ABR. Conclusion: The recurrence rate after ABR was not associated with the time elapsed and that repair strategies should augment the large humeral bone defect and use >3 anchors during ABR.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.